2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9,9'-spirobi[fluorene], 98% HPLC,T, 25g

Ethyl 2-methyl-1H-pyrrole-3-carboxylate, 98.0%, 25g

5-Bromo-2-thiophenecarboxylic Acid>98.0%(GC)(T)1g

Uric acid, min. 99%, for biochemistry, 50 g, glass packaging

(4-Nitro-pyrazol-1-yl)-acetic acid, 95.0%, 1g

4'-bromo-3-piperidinomethyl benzophenone, 97.0%, 1g

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyrimidin-2-amine, 95.0%, 1g

[3-(1H-Pyrazol-1-yl)phenyl]methylamine, 97.0%, 250mg

(3aS,8aR)-2-(6-Phenylpyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole, 97%, 50mg

N-Methyl-2-pyrimidinemethanamine, 95.0%, 1g

2-Fluorobenzyl bromide, 98.0%, 10g

Potassium 3-ethoxy-3-oxopropanoate, 98.0%, 5kg

2-(4-Methoxybenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g